Jiangsu Walvax Biotech Co.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Jiangsu Walvax Biotech Co.
A new review of adverse event data found reports tied to each of six endoscope categories rose significantly between 2014 and 2021. For gastroscopes, the rise was an eye-popping 8,630%.
Boston Scientific has received 510(k) clearance, launching it into a $1bn market where single-use scopes are increasingly recommended to prevent spread of infections.
The single-use scopes should be used in lieu of reprocessed devices when a significant infection risk exists, the US agency says.
With four new drug approvals notched under its belt in four months, GlaxoSmithKline had several potential growth drivers to highlight during its third quarter earnings call, helping to deflect attention away from the bribery scandal in China.